These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 18691904)

  • 1. Physicochemical and biological assays for quality control of biopharmaceuticals: interferon alpha-2 case study.
    Silva MM; Lamarre B; Cerasoli E; Rakowska P; Hills A; Bailey MJ; Wheeler JX; Burns CJ; Gaines-Das RE; Jones C; Robinson CJ
    Biologicals; 2008 Nov; 36(6):383-92. PubMed ID: 18691904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activity of EDQM CRS for Interferon alfa-2a and Interferon alfa-2b - assessment in two in vitro bioassays.
    Silva MM; Gaines-Das RE; Jones C; Robinson CJ
    Pharmeuropa Bio; 2007 Dec; 2007(1):1-6. PubMed ID: 18413132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency determination of recombinant IFN-alpha based on phosphorylated STAT1 using flow cytometry.
    de Oliveira ER; Lima BM; dos Santos BA; de Moura WC; Nogueira AC
    J Immunol Methods; 2012 Jan; 375(1-2):271-5. PubMed ID: 22115721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved detection of variants in recombinant human interferon alpha-2a products by reverse-phase high-performance liquid chromatography on a core-shell stationary phase.
    Li Y; Rao C; Tao L; Wang J; Lorbetskie B; Girard M
    J Pharm Biomed Anal; 2014 Jan; 88():123-9. PubMed ID: 24051275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of a monomethioninesulfoxide variant of interferon alpha-2b.
    Gitlin G; Tsarbopoulos A; Patel ST; Sydor W; Pramanik BN; Jacobs S; Westreich L; Mittelman S; Bausch JN
    Pharm Res; 1996 May; 13(5):762-9. PubMed ID: 8860434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and purification of recombinant, glycosylated human interferon alpha 2b in murine myeloma NSo cells.
    Rossmann C; Sharp N; Allen G; Gewert D
    Protein Expr Purif; 1996 Jun; 7(4):335-42. PubMed ID: 8776749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermal stability of the WHO international standard of interferon alpha 2b (IFN-alpha 2b): application of new reporter gene assay for IFN-alpha 2b potency determinations.
    Caserman S; Menart V; Gaines Das R; Williams S; Meager A
    J Immunol Methods; 2007 Jan; 319(1-2):6-12. PubMed ID: 17196611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in p48-ISGFgamma levels confers resistance to interferon-alpha2a in MHCC97 cells.
    Wu WZ; Sun HC; Gao YQ; Li Y; Wang L; Zhou K; Liu KD; Iliakis G; Tang ZY
    Oncology; 2004; 67(5-6):428-40. PubMed ID: 15714000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of recombinant human BMP-6 in Escherichia coli and its purification and bioassay in vitro].
    Yang JH; Zhao L; Yang S; Wu SQ; Zhang J; Zhu TH
    Sheng Wu Gong Cheng Xue Bao; 2003 Sep; 19(5):556-60. PubMed ID: 15969083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy.
    Lesinski GB; Kondadasula SV; Crespin T; Shen L; Kendra K; Walker M; Carson WE
    J Natl Cancer Inst; 2004 Sep; 96(17):1331-42. PubMed ID: 15339971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biological properties, assay, and standardization of interferon-alpha: a need for a WHO collaborative study.
    Mire-Sluis AR; Gaines Das R; Zoon K; Padilla A; Thorpe R; Meager A
    J Interferon Cytokine Res; 1996 Aug; 16(8):637-43. PubMed ID: 8877735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaborative study for establishment of an HPLC-method for batch consistency control of recombinant interferon-alfa-2.
    Buchheit KH; Daas A; Jönsson KH
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):7-27. PubMed ID: 12448030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation.
    Hermeling S; Schellekens H; Maas C; Gebbink MF; Crommelin DJ; Jiskoot W
    J Pharm Sci; 2006 May; 95(5):1084-96. PubMed ID: 16552750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of aggregation, denaturation and reduction of interferon alpha-2 products by size-exclusion high-performance liquid chromatography with fluorescence detection and biological assays.
    Diress A; Lorbetskie B; Larocque L; Li X; Alteen M; Isbrucker R; Girard M
    J Chromatogr A; 2010 May; 1217(19):3297-306. PubMed ID: 19931086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of methionine oxidation on the aggregation of recombinant human growth hormone.
    Mulinacci F; Poirier E; Capelle MA; Gurny R; Arvinte T
    Eur J Pharm Biopharm; 2013 Sep; 85(1):42-52. PubMed ID: 23958317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-interferon antibodies to interferon-alpha 2b: results of comparative assays and clinical perspective.
    Spiegel RJ; Jacobs SL; Treuhaft MW
    J Interferon Res; 1989 Sep; 9 Suppl 1():S17-24. PubMed ID: 2553829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the biological activities and physicochemical characteristics of recombinant bovine interferon-α₁₄.
    Shao J; Cao C; Bao J; Gao M; Wang J
    Mol Immunol; 2015 Mar; 64(1):163-9. PubMed ID: 25480392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of magnetic microspheres for the purification of interferon alpha-2b.
    Cao Y; Bai G; Chen J; Tian W; Wang S; Yang W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 833(2):236-44. PubMed ID: 16490407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-alpha 2b quantification in inclusion bodies using reversed phase-ultra performance liquid chromatography (RP-UPLC).
    Cueto-Rojas HF; Pérez NO; Pérez-Sánchez G; Ocampo-Juárez I; Medina-Rivero E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(13-14):1019-23. PubMed ID: 20299292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of therapeutic effects of low-dose versus high-dose interferon alpha-2b treatment on chronic myelocytic leukemia: a prospective randomized study].
    Du JW; Zhu P; Tian D; Dong ZR; Yang SL; Li SB; Tang YH; Liu H; Cen XN; Zhang Y; Zhu Q; Zhu YL; Yang Y; Wang DX; Wang Z; Cui H; Ma YG; Chen WM; Liu FQ; Ma J; Wang JW; Shen T; Da WM
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(19):1305-9. PubMed ID: 16029627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.